BeyondSpring

BYSINasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$35.774 M

$0.87 +0.00%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$1.01M

Loss-making

Shares outstanding

41,119,820

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#368NanoviricidesNNVC$36.1M
#369Serina TherapeuticsSER$36.0M
#370BeyondSpringBYSI$35.8M
#371EnlivexENLV$35.0M
#372Quantum CyberQUCY$32.8M

Where these numbers come from

Share counts and financials for BeyondSpring are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.